1,N6-Etheno-9-(β-D-xylofuranosyl)adenosine

Modify Date: 2024-03-01 10:58:27

1,N6-Etheno-9-(β-D-xylofuranosyl)adenosine Structure
1,N6-Etheno-9-(β-D-xylofuranosyl)adenosine structure
Common Name 1,N6-Etheno-9-(β-D-xylofuranosyl)adenosine
CAS Number 2095417-39-1 Molecular Weight 291.26
Density N/A Boiling Point N/A
Molecular Formula C12H13N5O4 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of 1,N6-Etheno-9-(β-D-xylofuranosyl)adenosine


1,N6-Etheno-9-(β-D-xylofuranosyl)adenosine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

 Names

Name 1,N6-Etheno-9-(β-D-xylofuranosyl)adenosine

  Biological Activity

Description 1,N6-Etheno-9-(β-D-xylofuranosyl)adenosine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Related Catalog
References

[1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.  

 Chemical & Physical Properties

Molecular Formula C12H13N5O4
Molecular Weight 291.26